IMDX logo

IMDX Insight Molecular Diagnostics Inc.

NASDAQ Capital Market · Medical - Diagnostics & Research · Healthcare

$2.51
+0.05 (+2.03%)

Insight Molecular Diagnostics Inc. functions as a molecular diagnostics firm specializing in the research, development, and market introduction of distinctive, laboratory-developed tests aimed at cancer identification. Its operations span both the United States and international territories. The company's key offerings include DetermaRx, a molecular diagnostic tool tailored for detecting early-sta…

Market Cap: $82.14Mimdxinc.com

Price

No data yet.

Social Signal Score

46
5d
50
1 mentions
—
30d
44
5 mentions
—
60d
44
5 mentions
—
90d
44
5 mentions
—
news: 5

Analyst Ratings

11 analysts
Buyconsensus
Strong Buy 0Buy 7Hold 4Sell 0Strong Sell 0
Avg price target$9.75+288.4%
Low $8Median $9.5High $12
Current Consensus

Revenue

$239.0K
$0.00$1.20M$2.39M$3.59M
Sep 2016Jun 2026

Analyst Estimates

FY2025
$-1.15
$-1.64–$-0.64
1 analysts
FY2026
$-0.90
$-0.91–$-0.90
3 analysts
FY2027
$-0.86
$-0.90–$-0.82
3 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Joshua Riggs
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
57
Beta
1.86
Country
US
Piotroski score
1 / 9 (Weak)
Altman Z-score
-23.89
imdxinc.com